"Phase III studies are randomized controlled multicenter trials on large patient groups (300–3,000 or more depending upon the disease/medical condition studied) and are aimed at being the definitive assessment of how effective the drug is, in comparison with current 'gold standard' treatment. Because of their size and comparatively long duration, Phase III trials are the most expensive, time-consuming and difficult trials to design and run, especially in therapies for chronic medical conditions"
http://en.wikipedia.org/wiki/Clinical_trial#Phase_II
"Phase III studies are randomized controlled multicenter trials...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
-0.015(4.41%) |
Mkt cap ! $472.0M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.8¢ | 32.5¢ | $718.9K | 2.181M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 183899 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |